Skip to main content

SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to re

Social Author Name
Dr. John Cush
Tweet Content
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to respond to standard doses of prednisone therapy, were significantly better when given the IL-6 inhibitor sarilumab (than placebo). https://t.co/k5SAshxdsg https://t.co/tMtRHn2C6j
Show on Archive Page
On
Display in Search Results
On
PDQ
Off